JJIJ
VOR icon

Johnson & Johnson Innovation - JJDC’s Vor Biopharma VOR Stock Holding History

Johnson & Johnson Innovation - JJDC’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$20M Hold
53,733
– – 2.05% 8
2021
Q1 		$46.3M Buy
+53,733
New +$45.5M 6% 5

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's VOR Position: Q2 2021 in Review

Johnson & Johnson Innovation - JJDC held its Vor Biopharma (VOR) position steady in Q2 2021 at 53,733 shares worth $20M. The position accounts for 2.05% of the portfolio, ranked #8.

Johnson & Johnson Innovation - JJDC first reported a position in VOR in Q1 2021 and has held it in 2 quarters since. The position peaked at $46.3M in Q1 2021. 51 funds tracked by Wall St. Rank hold VOR as of Q2 2021.

  • Johnson & Johnson Innovation - JJDC held 53,733 shares of Vor Biopharma worth $20M as of Q2 2021.
  • Johnson & Johnson Innovation - JJDC left its Vor Biopharma share count unchanged in Q2 2021.
  • Vor Biopharma made up 2.05% of Johnson & Johnson Innovation - JJDC's portfolio in Q2 2021, its #8 holding.
  • Johnson & Johnson Innovation - JJDC first reported a position in Vor Biopharma in Q1 2021 and has held it in 2 quarters since.
  • Johnson & Johnson Innovation - JJDC's Vor Biopharma position peaked at $46.3M in Q1 2021.
  • 51 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2021.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q2 2021, filed 3 Aug 2021.